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The gating of pentameric ligand-gated ion channels
is sensitive to a variety of allosteric modulators that
act on structures peripheral to those involved in
the allosteric pathway leading from the agonist site
to the channel gate. One such structure, the lipid-
exposed transmembrane a helix, M4, is the target
of lipids, neurosteroids, and disease-causing muta-
tions. Here we show that M4 interactions with the
adjacent transmembrane a helices, M1 and M3,
modulate pLGIC function. Enhanced M4 interac-
tions promote channel function while ineffective in-
teractions reduce channel function. The interface
chemistry governs the intrinsic strength of M4-M1/
M3 inter-helical interactions, both influencing chan-
nel gating and imparting distinct susceptibilities to
the potentiating effects of a lipid-facing M4 congen-
ital myasthenic syndrome mutation. Through aro-
matic substitutions, functional studies, andmolecular
dynamics simulations, we elucidate a mechanism by
which M4 modulates channel function.
INTRODUCTION
Pentameric ligand-gated ion channels (pLGICs), such as the
nicotinic acetylcholine receptor (nAChR), respond to neurotrans-
mitter binding by transiently opening either cation- or anion-se-
lective channels across the post-synaptic membrane. The sites
for agonist binding are located at the interfaces between sub-
units in the extracellular domain (ECD), which extends away
from the membrane surface into the synaptic cleft (Figure 1) (Un-
win, 2005). Agonist binding induces rigid body motions, which
are translated into transient movements of the pore lining M2
a helices of the transmembrane domain (TMD) by a series of
loops at the ECD/TMD interface (Althoff et al., 2014; Sauguet
et al., 2014; Unwin and Fujiyoshi, 2012). Considerable attention
has focused on elucidating the gating movements of these inter-
facial loops, which form the primary allosteric path leading fromStructure 23, 1655–16the agonist site to the channel gate (Grutter et al., 2005; Jha et al.,
2007; Lee and Sine, 2005; Lummis et al., 2005). In contrast,
structures not directly involved in the primary allosteric path
have received less attention, even though a number of allosteric
modulators influence gating via these auxiliary sites (Figure 1A).
The fourth transmembrane a helix, M4, is located on the
periphery of the TMD and is the target of both lipids and neuro-
steroids (Baenziger et al., 2015; Barrantes, 2003, 2015; Henault
et al., 2015; Hosie et al., 2006; Paradiso et al., 2001). Lipid-facing
mutations in M4 of the muscle-type nAChR influence channel
gating, with at least one leading to a congenital myasthenic
syndrome (CMS) (Bouzat et al., 1998; Lasalde et al., 1996; Lee
et al., 1994; Li et al., 1992; Shen et al., 2006; Tamamizu et al.,
2000). M4 extends beyond the bilayer to interact directly with
the b6-b7 loop (often referred to as the Cys-loop), a key structure
at the ECD/TMD interface that participates in channel gating.
One model proposes that interactions between M4 and the
adjacent a helices, M1 and M3, are dynamic, in that effective
M4-M1/M3 interactions lead to M4/Cys-loop contacts that
promote channel function, while ineffective M4-M1/M3 interac-
tions abolish M4/Cys-loop connections to reduce channel
function (daCosta and Baenziger, 2009; daCosta et al., 2013).
In this context, it is intriguing to note that of the four transmem-
brane a helices, M1–M4, M4 exhibits the greatest sequence
variability among the various Torpedo and human nAChR sub-
units. This variability should lead to subunit-specific interactions
at the interface between M4 and M1/M3, resulting in variable
interaction energies. If strong M4-M1/M3 interactions promote
coupling between the agonist site and channel gate, then vari-
able M4-M1/M3 interaction energies should lead to variable
coupling efficiencies. nAChR subunits with weak M4-M1/M3 in-
teractions should also be more sensitive to allosteric modulators
that act on M4.
The two structurally well-characterized prokaryotic pLGICs,
GLIC and ELIC (Figure 1) (Bocquet et al., 2009; Hilf and Dutzler,
2008, 2009; Pan et al., 2012; Sauguet et al., 2013), are excellent
models for probing the role of M4 in pLGIC function, as both
share a similar tertiary/quaternary fold yet have distinct M4
conformations. In GLIC, M4 interacts tightly with M1/M3 along
its entire length. In ELIC, the C-terminal half of M4 tilts away
from M1/M3 with the final five residues unresolved in the crys-
tal structure. Aromatic interactions are key determinants that64, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1655
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Figure 1. Structures of pLGICs with Bound Modulators
(A) Structures of the nAChR (PDB: 2BG9), GluCl (PDB: 3RIF), and GLIC (PDB:
3P50). In each case, a single subunit is shown as a dark-blue cartoon with the
M4 a helix highlighted in red. In the nAChR (left), residues in the agonist site are
highlighted as red spheres, while those forming the transmembrane gate are
highlighted as yellow spheres. In GluCl (center), the agonist glutamine, the
positive modulator ivermectin, the open channel blocker picrotoxin (aligned
using 3RI5), and a bound detergent molecule are highlighted as red, orange,
yellow, and marine spheres, respectively. In GLIC (right), the inhibitor propofol
and bound lipids (aligned from 3EAM) are shown as yellow and marine
spheres, respectively.
(B) A single TMD subunit of ELIC (left, 2VL0) and GLIC (right, PDB: 4HFI) with
residues at the M4-M1/M3 interface shown as spheres. Aromatic, polar
hydrogen bonding, positive, and aliphatic residues are highlighted in yellow,
green, blue, and tan, respectively. The marine sphere corresponds to a water
molecule.energetically drive the binding of M4 to M1/M3 during folding of
the homologous glycine receptor (Haeger et al., 2010). GLIC ex-
hibits an extensive network of interacting aromatic residues at
the M4-M1/M3 interface, including a cluster of three aromatic
residues that may be essential for linking the C terminus of M4
to both M1/M3 and the b6-b7 loop (see Figures 1B and 3).
Intriguingly, this C-terminal M4 aromatic cluster is absent in
ELIC. Through aromatic substitutions, functional studies, and
molecular dynamics simulations, we examine here the effects
of aromatic residues at the M4-M1/M3 interface on the confor-
mation of M4, and how the resulting changes in conformation
influence channel function. We also examine whether TMDmod-
ulators influence pLGIC function by modulating M4-M1/M3
interactions.1656 Structure 23, 1655–1664, September 1, 2015 ª2015 Elsevier LtRESULTS
Aromatic Residues Promote M4-M1/M3 Interactions
GLIC exhibits nine aromatic residues at the M4-M1/M3 inter-
face (Figure 1B), labeled as aromatics (1) M4 F315, (2) M4
F314, (3) M3 Y254, (4) M4 F303, (5) M3 F265, (6) M3 Y266,
(7) M1 W213, (8) M4 F299, and (9) M1 F216 (see Figure 3).
Although the aromatics at positions 4, 7, 8, and 9 are conserved
in ELIC, the entire M4 C-terminal aromatic cluster (aromatics
1–3) and the aromatic side chains at positions 5 and 6 on M3
are absent. We postulated that the distinct profiles of aromatic
interactions at the M4-M1/M3 interface in GLIC and ELIC lead
to the different conformations of M4 observed in the crystal
structures. The different M4 conformations, however, could
also result from differential crystal packing and/or detergent-
solubilization effects prior to crystallization (daCosta and Baen-
ziger, 2013).
To probe whether aromatic substitutions at the M4-M1/M3
interfaces influence the conformation of M4 in a folded pLGIC
structure located within a membrane environment, we turned to
molecular dynamics simulations. Simulations were run for both
wild-type GLIC (WT-GLIC) and a mutant where the five non-
conservedaromatic residuesweremutated toAla (5Ala-GLIC: ar-
omatic-to-Ala substitutions at positions 1, 2, 3, 5, and 6). In both
cases, simulations were performed using intact pentamers, as
well as with a single-subunit-TMD. Both sets were run in palmi-
toyl-oleoyl-phosphatidylcholine (POPC) bilayers, a membrane
that supports GLIC function (Labriola et al., 2013). The latter sim-
ulations revealed intriguing lipid binding poses, which are dis-
cussed below. Finally, simulations run for both wild-type ELIC
and an ELIC mutant with aliphatic-to-aromatic substitutions at
the same positions in the M4-M1/M3 interface were not informa-
tive because affected residues in the M4 C terminus are not
defined in the ELIC crystal structure, thus precluding a defined
starting conformation.
Consistent with our hypothesis, the simulations show that
aromatic residues at the M4-M1/M3 interface influence the
interactions of M4 with M1/M3. Specifically, the close contacts
between residues along the entire length of M4 and those on
M1/M3 in the GLIC crystal structure are maintained throughout
the simulations with WT-GLIC. In contrast, the loss of the
C-terminal aromatic cluster leads to a consistent tilting of the
C-terminal half of M4 away fromM1/M3, with closest Ca-Ca car-
bon atom contacts on M4-M1 and M4-M3 increasing by roughly
2 A˚ (Figures 2A and S1: the latter compares directly distances
between Y/A254 on M3 and both F/A314 and F/A317 on M4).
The differences in M4-M1/M3 interactions are statistically signif-
icant based on SEs calculated across the five subunits. The
magnitudes of the separations are larger than typical root-
mean-squared-deviations among the transmembrane Ca atoms
of different pLGICs (Bocquet et al., 2009; Hibbs and Gouaux,
2011; Hilf and Dutzler, 2009; Miller and Aricescu, 2014) or
between different conformations of GLIC (Sauguet et al., 2013).
The Ca carbon atom separations observed in the M4 C-terminal
region contrast with those observed between M4 and M1/M3
near the cytoplasmic side of the bilayer, where the Ca carbon
atom separations in 5Ala-GLIC and WT-GLIC converge
(Ca atoms separation differences are less than 1 A˚) (Figures 2A–
2C). The latter suggests that the aromatic interactions remainingd All rights reserved
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Figure 2. Aromatic Residues Promote M4-M1/M3 Interactions
(A) Transmembrane domain of WT-GLIC and 5Ala-GLIC following 300 ns of simulation. Helices are shown in surface representation (M1, green; M2, blue; M3,
dark gray; M4, orange), with substituted residues shown in stick representation (Y/A254, orange; F/A314, purple; F/A315, green). The M2-M3 loop (yellow) and a
portion of the ECD (purple) closest to the interface with the TMD are also shown in surface representation. POPC lipid density, averaged over the final 200 ns of the
simulation, is represented by a translucent blue isosurface; the submerged appearance of the 5Ala-GLIC M4 a helices relative to those of WT-GLIC reflects
significant lipid penetration of the 5Ala-GLIC subunits.
(B) Representative subunit fromWT-GLIC (left) and 5Ala-GLIC (center), showing POPC lipids bound to the M1-M4 interface in stick representation with blue acyl
chains and red PC headgroups. A rotated view of 5Ala-GLIC (right) shows a second POPC molecule bound to 5Ala-GLIC, with cyan acyl chains and pink PC
headgroups, straddling the 5Ala-GLIC M3-M4 interface. Lines represent the membrane-water interface.
(C) Average distances between Ca atoms on residues at similar register on opposing helices. Substituted residues are highlighted in red. Error bars represent the
SE across the five subunits.
(D) Free energy landscape (potential of mean force) for configurations of F314 and F315 relative to Y254 in four of five WT-GLIC subunits, as a function of angle
between planar groups and centroid-centroid distance (Equations 1 and 2 in the Supplemental Information). In a fifth subunit, the aromatic cluster disassociates
early in the simulation, as discussed further in Figure S2. The blue symbol in each panel indicates the value of the corresponding angle and distance determined
from the crystal structure (PDB: 4HFI).
See also Table S1; Figures S1 and S2.in the intracellular leaflet of 5Ala-GLIC are sufficient to maintain
effective M4-M1/M3 interactions in this region.
The tilt of the C-terminal half of M4 observed in the simulations
of the 5Ala-GLIC mutant suggests that aromatic residues are
essential for promoting effective M4-M1/M3 interactions. Note
that the observed tilt of M4 away from M1/M3 in the simulations
of 5Ala-GLIC is similar, but of lesser magnitude than the tilt of M4
observed in the crystal structure of ELIC. In the ELIC crystal
structure, the terminal five residues are unresolved, suggesting
weak, if any, interaction between the M4 C terminus and M1/
M3. The ELIC crystal structure supports the conclusion that
aromatic residues at the M4-M1/M3 interface promote M4 inter-
actions with M1/M3. Detergent solubilization and the removal of
lipidsmay perturb the intrinsically weak interactions between theStructure 23, 1655–16M4C-terminus andM1/M3, leading to a greater disruption of M4
conformation than observed in the simulations.
The aromatic-to-Ala substitutions have a substantial effect on
the energetics ofM4-M1/M3 interactions. InWT-GLIC,M4C-ter-
minal aromatics 1, 2, and 3 are involved in pairwise interactions
within the aromatic cluster, with Ala substitutions of these resi-
dues leading to energetic penalties of >1 kcal/mol (Table S1).
For four of the five subunits, the two-dimensional free energy
landscape (Figure 2C) calculated from the relative orientations
of M3:Y254 (3) and M4:F315 (1) aromatic groups has a strong
angular dependence consistent with p-p stacking interactions,
with the minima near 90 indicating a T-shaped conformation
similar to that found in the crystal structure. In the fifth sub-
unit, F315 dissociates from the cluster and rotates to face the64, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1657
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Figure 3. Enhanced M4-M1/M3 Interactions
Potentiate pLGIC Function
(A) The TMD of a single subunit of an ELIC homol-
ogy model (based on GLIC, PDB: 3EHZ). Aromatic
residues conserved in GLIC and ELIC are shown in
yellow, while aromatics removed from GLIC or
inserted into ELIC are shown in orange, super-
imposed on wild-type (WT) ELIC residues (red). The
M4 sequence alignments highlight key aromatic
residues (boxed), and identical (*), conserved (:),
and semi-conserved (.) residues.
(B) Two-electrode data for GLIC (upper) and ELIC
(lower), with representative mutants. Ligand con-
centration jumps (protons or cysteamine for GLIC
and ELIC, respectively) are indicated by the hori-
zontal bar.
(C) Dose-response curves obtained for single
aromatic-to-Ala substitutions in GLIC (upper) and
from either single and multiple aliphatic-to-aro-
matic substitutions in ELIC (lower). Error bars
represent SE.
(D) Changes in EC50 relative to the WT for GLIC
(pH 5.03) and ELIC (0.92 mM cys). NC, no current.
Multiple aromatic substitutions were not generated
for GLIC (X). Error bars represent SD. See Table S2
for EC50 values.
See also Table S2 and Figure S3.lipids, as also observed in the single-subunit-TMD simulations
(Figure S1).
M4 C-terminal aromatics 1, 2, and 3 are also involved in pair-
wise interactions with other residues that strengthen M4-M3 in-
teractions. An additional strong energy penalty is associated
with the loss of a hydrogen bond between the tyrosine hydroxyl
of M3:Y254 (aromatic 3) and the carbonyl oxygen of M4:N307.
These two residues hydrogen bond via a bridging water in four
out of five chains of the highest-resolution crystal structure for
GLIC (Sauguet et al., 2013). In the simulations, bridging waters
are observed transiently, interspersed with direct hydrogen
bonding between the two residues. Also, the mutations weak-
ened several pairwise interactions involving aromatic substitu-
ents and non-aromatic polar or hydrophobic residues (Table S1).
One intriguing finding of the simulations is that the tilt of theM4
C terminus away fromM1/M3 and/or the reduced side-chain vol-
ume in 5Ala-GLIC leads to a change in lipid binding. In WT-GLIC,
POPCmolecules adopt poses at the edge of theM4-M1 andM4-
M3 interfaces, as in the GLIC crystal structures. In 5Ala-GLIC,
the POPCmolecules penetrate deeper into the M1/M3/M4 a-he-
lical bundle, with entire acyl chains becoming embedded at the
M1-M4 interface (Figures 2C and 2D). A second POPC assumes
a pose in a cavity formed by the C-terminal end of M4, the M2-
M3 loop, and the b6-b7 loop (Figure 2D), where one acyl chain
fills the increased free volume vacated by M4 F314 and F3151658 Structure 23, 1655–1664, September 1, 2015 ª2015 Elsevier Ltd All rights reservedupon mutation of each residue to Ala,
while the other acyl chain remains in con-
tact with the bulk membrane (Figure 2D).
Such interactions are seen across sub-
units, with one lipid at least partially buried
in each of these sites. Buried lipids could
potentially mediate some of the effects
of the aromatic substitutions, by direct in-teractions with the M2-M3 and b6-b7 loop and/or indirectly by
stabilizing M4 in a conformation with reduced interactions with
the ECD. This possibility underscores the potential significance
of even slight conformational changes in M4, particularly if they
increase the free volume at the M4-M1/M3 interface above the
volume required to accommodate a buried lipid. Note also that
in single-subunit-TMD simulations, the absence of steric con-
flicts with the ECD allows even deeper penetration of the lipid.
It appears that even subtle changes in conformation can dramat-
ically alter lipid binding (Figure S3).
Weakened M4-M1/M3 Interactions Inhibit Channel
Function
To test experimentally whether M4 conformation influences
channel function, non-conserved aromatic residues in GLIC
were individually mutated to Ala to weaken M4-M1/M3 interac-
tions, and the effects of the individual substitutions on channel
function were assessed using the two-electrode voltage-clamp
apparatus. WT-GLIC gates open in response to protons, with a
pH value required to elicit half-maximal channel gating of
pH50 = 5.03 ± 0.08 (n = 38). Each individual aromatic-to-Ala
mutation led to a rightward shift in the dose response to protons,
with the pH50 values decreasing by 0.4 to 0.9 pH units: the
Y266A mutation at position 6 (Figure 3) gave rise to the largest
shift down to a pH50 = 4.12 ± 0.07 (n = 8). The shifts in pH50
correspond to 2- to 8-fold increases in the concentrations of pro-
tons required for activation (Figure 3; Table S2). Simultaneous
aromatic-to-Ala substitutions of interacting aromatic pairs were
also generated, but none of the double mutants gave observable
proton-activated currents. The absence of current could reflect
impaired channel function and/or folding and then trafficking to
the cell surface (Haeger et al., 2010).
Note that the pH50 values derived from macroscopic currents
depend on both the affinity of the agonist for its binding site and
the equilibrium constant governing transitions from closed to
open states. In addition, desensitization kinetics can influence
the measurement of pH50 values. Most of the mutations have lit-
tle effect on the macroscopic desensitization rates (Figure S3).
Given that the proton binding sites for activation are mainly
distant from the TMD (Duret et al., 2011), the majority of the
changes in pH50 likely reflect changes to the equilibrium constant
governing channel gating; the decreased pH50 values thus likely
reflect impaired coupling between agonist binding and channel
gating. This interpretation, however, is not unequivocal, as a
His235 located on the adjacent M2 a helix influences proton acti-
vation of GLIC (Rienzo et al., 2014; Wang et al., 2012). In partic-
ular, the Y266A could directly influence the pH50 for gating via
this intramembrane protonation site.
Enhanced M4-M1/M3 Interactions Potentiate Channel
Function
In contrast to the mutations in GLIC, individual aliphatic-to-
aromatic substitutions introduced at the M4-M1/M3 interface
to enhance M4-M1/M3 interactions in ELIC each shifted the
dose response to cysteamine leftward, whether or not interact-
ing aromatic partners on the adjacent transmembrane a helices
were present (Figure 3; Table S2).Wild-type ELIC required a con-
centration of cysteamine to elicit half-maximal channel gating of
EC50 = 0.94 ± 0.16 mM cysteamine (n = 23). Of the individual
aliphatic-to-aromatic mutations, G218F (2) led to the largest
reduction in EC50 = 0.44 ± 0.09 mM cysteamine (n = 13). The
changes in EC50 values correspond to between 70% and 50%
reductions in the concentrations of cysteamine required. Multi-
ple aromatic additions were also introduced, and these led to
even further leftward shifts in the EC50 values. Engineering either
the entireM4C-terminal aromatic cluster (EC50 = 0.18 ± 0.02mM
cysteamine [n = 9]) or the entire aromatic network of GLIC into
ELIC (EC50 = 0.15 ± 0.04 mM cysteamine [n = 7]) shifted the
EC50 down to a value approaching 10% of the EC50 value of
wild-type ELIC. In fact, the largest reductions in EC50 were
observed with just two interacting aromatic partners engineered
into the M4 C-terminal region, one on M3 and the other on M4.
Both the I319F/V260Y and G318F/V260Y double mutants gave
EC50 values of 0.13 mM cysteamine.
The leftward shifts in the dose response observed with aro-
matic ‘‘additions’’ in ELIC contrast with the rightward shifts
observed with aromatic ‘‘deletions’’ in GLIC, with leftward shifts
reflecting a gain, as opposed to a loss, of channel function. In
contrast to GLIC where the proton-sensitive intramembrane
His235 complicates the interpretation of pH50 values, the agonist
binding site in ELIC is greater than 30 A˚ distant from even the
closest mutations at the M4-M1/M3 interface, suggesting that
the mutations do not directly influence the chemistry of the
agonist site and, thus, agonist affinity. Furthermore, mutationsStructure 23, 1655–16in M4 of the nAChR have been shown to have no effect on
agonist affinity (Bouzat et al., 2000; Mitra et al., 2004; Shen
et al., 2006). Although single-channel measurements are
required to confirm that the changes in EC50 result from direct
effects on channel gating, the long distance between M4 and
the agonist site suggests that the changes in EC50 detected
here reflect enhanced channel function; i.e., enhanced coupling
between agonist binding and channel gating. The gain-of-func-
tionmutations show that residues along theM4-M1/M3 interface
in wild-type ELIC are not optimized to promote M4-M1/M3 inter-
actions that support channel function, and that improving the
effectiveness of these interactions promotes coupling between
the agonist site and channel gate.
We considered the possibility that aromatic additions to the
M4-M1/M3 interface promote more effective interactions with
bound lipids to enhance function. Interactions between the
F315 aromatic residue in GLIC and lipids are observed in both
the pentamer and single-subunit-TMD simulations. The lipid-
facing F317 and F312 residues were mutated to alanine, leading
to gain-of-function and loss-of-function phenotypes, respec-
tively (F317A pH50 = 5.41 ± 0.05 [n = 8], F312A pH50 = 4.50 ±
0.01 [n = 6]). These results show that it is impossible to predict
how interactions between aromatic residues and lipids will influ-
ence channel function.
Finally, an important feature of our results is the consistency
of the entire dataset. Every aromatic-to-Ala substitution at the
M4-M1/M3 interface in GLIC led to reduced channel function
while every aliphatic-to-aromatic substitution at the same inter-
face in ELIC led to enhanced channel function. The latter is
particularly compelling, given that although optimal aromatic
interactions enhance inter-a-helical interactions, the insertion
of aromatic side chains at the M4-M1/M3 interface could lead
to structural and/or chemical conflicts and, thus, a loss of chan-
nel function. The data highlight the ease with which effective
interactions between M4 and M1/M3 in ELIC can be formed
to enhance channel function. The consistency of the data sug-
gests that the changes in function are not due to localized
changes in structure, which would be expected to have random
effects. The molecular dynamics simulations support the
hypothesis that aromatic residues at the M4-M1/M3 interface
enhance M4-M1/M3 interactions. The gains of function
observed with aliphatic-to-aromatic residue substitutions in
ELIC thus result, at least in part, from enhanced M4 interactions
with M1/M3.
A Lipid-Facing CMS Mutation Potentiates Function by
Enhancing M4-M1/M3 Interactions
If M4-M1/M3 interactions in ELIC are intrinsically weaker than in
GLIC, leading to relatively poor coupling between the agonist
site and channel gate, ELIC may exhibit a greater capacity for
potentiation by allosteric modulators that enhance M4-M1/M3
interactions. To test this hypothesis, we focused on a CMS mu-
tation that occurs on the lipid-facing surface of aM4 in the human
muscle-type nAChR (C418W). C418W potentiates nAChR chan-
nel function roughly 25-fold (EC50 = 9.11 ± 1.45 mMacetylcholine
[n = 31] for wild-type, EC50 = 0.34 ± 0.08 mMacetylcholine [n = 11]
for C418W) by directly altering M4-lipid interactions, although
the mutation must ultimately influence interactions between
M4 and the remainder of the TMD (Figure 4; Table S3).64, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1659
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Figure 4. A CMS Trp Mutation Potentiates
Channel Function by Enhancing M4-M1/M3
Interactions
(A) Side and top views of the TMD of a single subunit
of human a1ChR (homology model based on PDB:
2BG9). Aromatics at the M4-M1/M3 interface are
shown in yellow. The lipid-facing residue aC418 is
shown as a solid orange sphere, with the potenti-
ating aC418Wmutation superimposed as an orange
sphere/stick transparent combination.
(B) Proposed mechanism of function for the potenti-
ating effect of aC418W via enhanced M4-M1/M3 in-
teractions. In the absence of M4 C-terminal aromatic
contacts, interaction of the bulky aC418W with the
lipid bilayer causes M4 to interact more tightly with
M1/M3 (red arrow), potentiating activity. In the pres-
ence of M4 C-terminal aromatics, M4 already in-
teracts tightly withM1/M3, so aC418Whas no effect.
(C–E) Two-electrode data (left) and dose-response
curves (right) demonstrating the effect of the aC418
(or equivalent) mutation on (C) human muscle-type
nAChR, (D) ELIC (L308W), and (E) GLIC (L304W).
Error is represented as SE.
(F) Effect of the L308W mutation on aromatic-
substituted ELIC mutants, shown as change in EC50
relative to WT ELIC. Error is represented as SD, and
mutant numbers correspond to those in Figure 2A.
See Table S3 for complete EC50 values.
See also Figure S4.A leucine residue is found in both GLIC and ELIC at the
equivalent position. This Leu residue (L304) residue in GLIC
was changed to both Cys and Trp, but neither substitution
had any effect on channel function (pH50 = 5.03 ± 0.02
[n = 6] and pH50 = 5.06 ± 0.03 [n = 6]), respectively, possibly
because the extensive aromatic network at the M4-M1/M3
interface already promotes effective M4-M1/M3 interactions
(Figure 4). In contrast, the same L308C and L308W mutations
in ELIC both led to gain-of-function phenotypes, with the
magnitude of the L308W gain of function (EC50 = 0.29 ±
0.05 mM cysteamine [n = 10]) approaching 5-fold relative to
the wild-type ELIC. Significantly, the introduction of interacting
aromatic residues to enhance intrinsic M4-M1/M3 interactions
reduced the potentiating effects of this CMS mutation in ELIC.
In fact, L308W had no further effect on the gating of ELIC
mutants containing either the three M4 C-terminal cluster aro-1660 Structure 23, 1655–1664, September 1, 2015 ª2015 Elsevier Ltd All rights reservedmatics or all five aromatic substitutions.
L308W thus potentiates ELIC function in
a manner similar to that observed with
the introduction of aromatic residues at
the M4-M1/M3 interface. These results
show that (1) altered lipid-protein inter-
actions promote channel function by
enhancing M4-M1/M3 interactions, and
(2) the intrinsic strength of M4-M1/M3 in-
teractions influences the functional sensi-
tivity of a pLGIC to altered protein-lipid
interactions, including mutations at the
lipid-protein interface. The CMS mutation
was also superimposed onto various aro-
matic-to-Ala substituted GLIC mutants,but none of these gave proton-activated currents (data not
shown).
Propofol Inhibits Channel Function via an
M4-Independent Mechanism
M4-M1/M3 interactions might play a role in the allosteric effects
of other TMD modulators, such as the inhibitory drug propofol.
Propofol binds to GLIC near the extracellular surface of the
TMD in a cavity delineated by the four transmembrane a helices
and capped by the b6-b7 loop, with the most extensive interac-
tions occurring between M1 and M3 (Nury et al., 2011). We
tested the possibility that propofol inhibits effective M4-M1/M3
interactions by investigating the effects of propofol on several
of the aromatic-substituted mutants of both GLIC and ELIC.
None of the aromatic-to-Ala substitutions at the M4-M1/M3
interface of GLIC or the aliphatic-to-aromatic substitutions at
the same interface in ELIC, however, had a major effect on pro-
pofol inhibition (Figure S4). In contrast to our hypothesis, propo-
fol does not inhibit gating bymodulatingM4-M1/M3 interactions,
consistent with both mutational and simulation studies, which
suggest that propofol inhibition results from binding closer to
the M2 pore lining the a helix (Nury et al., 2011), or even from
within the channel pore (LeBard et al., 2012).
DISCUSSION
Although there are likely other sites of action (Althoff et al., 2014;
Brannigan et al., 2008; Jones andMcNamee, 1988), a role for M4
in lipid sensing is highlighted by the identification of M4-bound
lipids in the crystal structure of GLIC (Bocquet et al., 2009), as
well as by mutagenesis data showing that changes in nAChR
M4-lipid interactions influence channel function (Bouzat et al.,
1998; Lasalde et al., 1996; Lee et al., 1994; Li et al., 1992; Shen
et al., 2006; Tamamizu et al., 2000). M4 is also the site of action
for neurosteroids (Hosie et al., 2006; Paradiso et al., 2001). In
addition, a lipid-facingmutation onM4 in themuscle-type nAChR
potentiates channel activity, leading to a CMS (Shen et al., 2006).
M4, however, is distant from the channel-liningM2 a helix, aswell
as key structures that form the primary allosteric path between
the agonist site and the channel gate (i.e., the b1-b2 and b6-b7
loops, the M2-M3 linker), thus raising the question of how
changes in M4 structure alter channel function.
Our data show that enhanced M4-M1/M3 interactions poten-
tiate pLGIC function while reduced interactions inhibit pLGIC
function. This conclusion is based on four observations. First,
molecular dynamics simulations show that aromatic residues
at the M4-M1/M3 interface promote strong M4-M1/M3 interac-
tions, with the elimination these aromatic residues leading to
increased Ca-Ca carbon atom separations between M4 and
M1/M3. Second, aromatic substitutions that promote M4-M1/
M3 interactions enhance channel function while aromatic sub-
stitutions that weaken M4-M1/M3 interactions reduce channel
function. Third, aromatic substitutions that modulate M4-M1/
M3 interactions influence the potentiating effects of a lipid-facing
M4CMSmutation. No potentiation was observed when the CMS
mutation was introduced into GLIC, which exhibits intrinsically
effective M4-M1/M3 interactions, while strong potentiation was
observed with ELIC, which lacks M4-M1/M3 stabilizing aromatic
interactions. Significantly, engineering aromatic interactions into
the M4-M1/M3 interface in ELIC abrogates the potentiating
response. Finally, the strength of M4-M1/M3 interactions has
no effect on the inhibitory effects of the drug propofol, which
acts at a TMD site that does not directly involve M4 (LeBard
et al., 2012; Nury et al., 2011).
Our proposed model of M4 action is supported by biophysical
studies, which have shown that the orientation of nAChR M4,
and thus presumably the interactions between M4 and M1/
M3, is sensitive to its surrounding lipid environment (Antollini
et al., 2005; Xu et al., 2005). The nAChR M4 moves halfway
along the reaction coordinate between agonist binding and
the open state (Mitra et al., 2004). Motion of M4 has also been
detected during desensitization of GLIC (Velisetty et al., 2014),
consistent with the desensitization effects observed here with
some of the M4-M1/M3 interface aromatic residue substitutions
(Figure S3).Structure 23, 1655–16There appears to be a particularly important role for the M4 C
terminus in pLGIC function, in agreement with the proposed role
of the M4 C terminus in lipid sensing by the muscle-type nAChR
from Torpedo. Increasing levels of cholesterol and anionic lipids
stabilize increasing proportions of agonist-responsive nAChRs
(Baenziger et al., 2000; daCosta et al., 2002, 2009; Hamouda
et al., 2006). In the absence of these activating lipids, the nAChR
adopts an uncoupled conformation that exhibits resting-state-
like agonist binding, but does not usually undergo agonist-
induced conformational transitions (Baenziger et al., 2008;
daCosta and Baenziger, 2009; daCosta et al., 2013). The M4
C terminus in both the nAChR and GLIC interacts directly with
the b6-b7 loop, an important link between the agonist site and
the transmembrane gate (Jha et al., 2007; Lee et al., 2009).
The M4 C terminus also interacts with M3 adjacent to the M2-
M3 linker, a structure that controls the orientation of the M2
gating a helix. Tighter M4 interactions with M1/M3 may facilitate
interactions between the M4 C terminus and the b6-b7-loop, to
form a b6-b7-loop conformation that participates optimally in
channel gating (daCosta and Baenziger, 2009). Interestingly,
the M4 C terminus does not interact directly with the b6-b7
loop in the ELIC crystal structure, which is significant because
crystallized ELIC does not undergo channel gating (Gonzalez-
Gutierrez et al., 2012). Weak M4 C-terminal interactions with
M1/M3, as a consequence of detergent solubilization, may
lead ELIC to adopt an uncoupled conformation (daCosta and
Baenziger, 2013).
Finally, a key finding of our study is the demonstration
that variable chemistry at the interface between M4 and M1/
M3 in different pLGICs leads to variable M4-M1/M3 interac-
tions, different ‘‘efficiencies’’ of coupling binding to gating, and
different susceptibilities to potentiation by allosteric modulators,
in this case a CMSmutation that acts on M4. GLIC has an exten-
sive aromatic network at this interface that leads to effective
M4-M1/M3 interactions along the entire length of M4, rendering
the TMD less malleable and less sensitive to M4-targeting mod-
ulators. GLIC is insensitive to the potentiating effects of the lipid-
facing M4 CMS mutation. GLIC also maintains efficient gating in
lipid environments that stabilize an uncoupled nAChR (Labriola
et al., 2013). ELIC, with no aromatic interactions in the C-terminal
half of M4, exhibits weak M4-M1/M3 interactions in this region.
ELIC is more sensitive than GLIC to M4-targeting modulators,
such as the CMS mutation and lipids, although aromatic substi-
tutions at the M4-M1/M3 abrogate sensitivity to both (Carswell
et al., 2015). The nAChR, with relatively few inter-a-helix aro-
matic interactions, likely exhibits relatively weak M4-M1/M3
interactions along the entire length of M4, and is even more sen-
sitive than ELIC to both the CMS mutation and lipids. Note that
although the Torpedo nAChR structure does not exhibit tight in-
teractions between M4 and M1/M3, M4 is not tilted away from
M1/M3 as it is in the ELIC structure. The nAChR structure, how-
ever, was solved by cryo-electron microscopy using native
nAChR membranes (Unwin, 2005; Unwin and Fujiyoshi, 2012),
while the ELIC structure was solved by X-ray diffraction using
crystals formed from detergent-solubilized ELIC (Hilf and Dut-
zler, 2008; Pan et al., 2012). In the native Torpedo membranes,
there are ‘‘activating’’ lipids (cholesterol, anionic lipids, etc.)
that stabilize a functional conformation, whereM4may associate
effectively with M1/M3.64, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1661
The chemistry at the M4-M1/M3 interface varies across hu-
man nAChR subunits, suggesting that human nAChRs exhibit
variable M4-M1/M3 interactions, and thus possibly different
sensitivities to allosteric modulators that act on M4. Knowledge
of the subunit-specific roles of M4 in nAChR function may
prove to be important for understanding the mechanisms by
which cholinergic activity is modulated by changes in lipid
composition that occur during the course of neurodegenerative
disease.EXPERIMENTAL PROCEDURES
RNA Constructs for Oocyte Expression
GLIC-pMT3 was kindly provided by Dr. Pierre-Jean Corringer (Bocquet et al.,
2009). The GLIC coding sequence was transferred to pSP64 without the C-ter-
minal hemagglutinin tag. ELIC-pTLN was kindly provided by Dr. Raimund
Dutzler (Zimmermann et al., 2012). A C-terminal Ala, a cloning artifact not
present in the GenBank sequence (GenBank: POC7B7), was removed. Both
the GLIC and ELIC plasmids have the a7 nAChR signal sequence followed
by the GLIC or ELIC coding sequence. ELIC-pTLN and GLIC-pSP64 were line-
arized by MluI and EcoRI, respectively, and used to produce capped cRNA by
in vitro transcription using the mMESSAGE mMACHINE SP6 kit (Ambion).
All mutants were created using QuikChange site-directed mutagenesis kits
(Agilent) and verified by sequencing.
Electrophysiology
Stage V–VI oocytes were isolated as previously described (Laitko et al.,
2006). Oocytes were injected with the indicated amount of mRNA and
allowed to incubate for 1 to 4 days at 16C in ND96 + buffer (5 mM HEPES,
96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 2 mM pyruvate).
Injected oocytes were placed in a RC-1Z oocyte chamber (Harvard Appa-
ratus) containing the appropriate buffer (see below). Whole-cell currents
were recorded using a two-electrode voltage-clamp apparatus (OC-725C
oocyte clamp; Harvard Apparatus). The whole-cell currents were recorded
while the appropriate buffer flowed through the oocyte chamber at a rate of
5–10 ml/min.
For GLIC, whole-cell currents were recorded from injected oocytes
(3–13 ng cRNA) immersed in MES (2-(N-morpholino)ethanesulfonic acid)
buffer (140 mM NaCl, 2.8 mM KCl, 2 mM MgCl2, and 10 mM MES). Currents
through the plasma membrane in response to pH jumps (pH 7.3 down to the
indicated pH values) were measured with the transmembrane voltage
clamped at voltages between 10 and 60 mV depending on the level of
expression of eachmutant GLIC. In the majority of cases, the holding potential
was 20 mV. For ELIC, whole-cell currents were recorded from injected
oocytes (0.2–10 ng cRNA) immersed in HEPES buffer (150 mM NaCl,
0.5 mM BaCl2 10 mM HEPES [pH 7.0]). In most cases, currents through the
plasma membrane in response to cysteamine concentration jumps (from
0 mM up to the indicated values) were measured with the transmembrane
voltage clamped at 40 mV.
Propofol (2,6 diisopropylphenol) was obtained from Aldrich (D126608). A
stock solution was made by diluting liquid propofol to 1 M in DMSO. This so-
lution was stored in glass in the dark, and diluted in MES or HEPES buffer
immediately before use. Each oocyte was exposed to at most two different
propofol concentrations. To avoid cumulative inhibitory effects, GLIC and
ELIC IC50 values were obtained through repeated measurement of relative in-
hibition caused by one concentration of propofol on a single oocyte, multiple
times. The average inhibitory values at each concentration were used in calcu-
lation of the IC50 using Prism’s log (inhibitor) versus response (three-param-
eter) analysis.
Dose responses for each mutant were acquired from at least two different
batches of oocytes. Each individual dose-response experiment was fit with
a variable slope sigmoidal dose response, and the individual EC50 and Hill
coefficients from each experiment averaged to give the values ± SD. For the
presented dose-response curves, the individual dose responses for each
experiment were normalized and each data point averaged. Curve fits of the
averaged data are presented, with the error bars referring to the SE.1662 Structure 23, 1655–1664, September 1, 2015 ª2015 Elsevier LtMolecular Dynamics Simulations
Two systems containing GLIC from PDB: 4HFI (Sauguet et al., 2013) were
prepared by protonating residues according to their standard states at pH
4.6, followed by either no mutations (WT-GLIC) or five simultaneous mutations
(5Ala-GLIC) corresponding to the sites 1, 2, 3, 5, and 6 investigated in the ex-
periments. Resolved lipids in the PDB structure were not included, although
after about 50 ns of simulation, lipids bound to WT-GLIC in poses similar to
those in PDB: 4HFI. For each system, the intact pentamer was placed in
a 110 3 110 A˚ POPC membrane aligned parallel to the xy plane using
CHARMM-GUI Membrane Builder (Jo et al., 2009). The system was solvated
with a total height in z of 155 A˚ and neutralized, for a total of about 175,000
atoms per system. Atomistic molecular dynamics simulations were run with
NAMD v2.9 (Phillips et al., 2005). The CHARMM36 force field was used for pro-
tein (Best et al., 2012; MacKerell et al., 1998) and phospholipid (Klauda et al.,
2010) parameters, with parameters for TIP3P waters (Jorgensen et al., 1983)
and ions (Beglov and Roux, 1994) corresponding to those traditionally used
with CHARMM-based force fields. All simulations used periodic boundary
conditions and particle mesh Ewald electrostatics. For more details, see Sup-
plemental Information.
SUPPLEMENTAL INFORMATION
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